EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 24 / No 1 (Janvier 2008) Med Sci (Paris), 24 1 (2008) 56-60 References
Free Access
Issue
Med Sci (Paris)
Volume 24, Number 1, Janvier 2008
Page(s) 56 - 60
Section M/S revues
DOI https://doi.org/10.1051/medsci/200824156
Published online 15 January 2008
  1. Sansonetti P. Plaidoyer pro domo vaccino. Med Sci (Paris) 2007; 23 : 342–4. [Google Scholar]
  2. Kaufmann SHE, McMichael AJ. Annulling a dangerous liaison : vaccination strategies against AIDS and tuberculosis. Nat Med 2005; 11 : S33–44. [Google Scholar]
  3. Leclerc C. L’apport des nouvelles technologies en vaccinologie. Med Sci (Paris) 2007; 23 : 386–90. [Google Scholar]
  4. Guillet JG, Lai MZ, Briner TJ, et al. Interaction of peptide antigens and class II major histocompatibility complex antigen. Nature 1986; 324 : 260–2. [Google Scholar]
  5. Guillet JG, Lai MZ, Briner TJ, et al. Immunological self, nonself discrimination. Science 1987; 235 : 865–70. [Google Scholar]
  6. Bouillot M, Choppin J, Cornille F, et al. Physical association between MHC molecules and immunogenic peptides. Nature 1989; 339 : 473–5. [Google Scholar]
  7. Choppin J, Martinon F, Gomard E, et al. Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides. J Exp Med 1990; 172 : 889–99. [Google Scholar]
  8. Connan F, Hlavac F, Hoebeke J, et al. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur J Immunol 1994; 24 : 777–80. [Google Scholar]
  9. Ostankovitch M, Guichard G, Connan F, et al. A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope. J Immunol 1998; 161 : 200–8. [Google Scholar]
  10. Choppin J, Cohen W, Bianco A, et al. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes : wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol 2001; 166 : 6164–9. [Google Scholar]
  11. Culmann-Penciolelli B, Lamhamedi-Cherradi S, Couillin I, et al. Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 nef protein. J Virol 1994; 68 : 7336–43. [Google Scholar]
  12. Couillin I, Culmann-Penciolelli B, Gomard E, et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 Nef protein. J Exp Med 1994; 180 : 1129–34. [Google Scholar]
  13. Dalod M, Dupuis M, Deschemin JC, et al. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8+ responses in HIV type 1-infected patients : comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol 1999; 73 : 7108–16. [Google Scholar]
  14. Martinon F, Gras-Masse H, Boutillon C, et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J Immunol 1992; 149 : 3416–22. [Google Scholar]
  15. Deprez B, Sauzet JP, Boutillon C, et al. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL. Vaccine 1996; 14 : 375–82. [Google Scholar]
  16. Bourgault I, Chirat F, Tartar A, et al. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides. J Immunol 1994; 152 : 2530–7. [Google Scholar]
  17. Mortara L, Gras Masse H, Rommens C, et al. Type 1 CD4+ T-cell help is required for induction of anti-peptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques. J Virol 1999; 73 : 4447–51. [Google Scholar]
  18. Le Gal FA, Prevost-Blondel A, Lengagne R, et al. Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study. Int J Cancer 2002; 98 : 221–7. [Google Scholar]
  19. Choppin J, Cohen W, Bianco A, et al. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes : wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol 2001; 166 : 6164–9. [Google Scholar]
  20. Cohen W, Bianco A, Connan F, et al. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1. J Virol 2002; 76 : 10219–25. [Google Scholar]
  21. Andrieu M, Desoutter JF, Loing E, et al. Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells. J Virol 2003; 77 : 1564–70. [Google Scholar]
  22. Molinier-Frenkel V, Lengagne R, Gaden F, et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 2002; 76 : 127–35. [Google Scholar]
  23. Molinier-Frenkel V, Prevost-Blondel A, Hong SS, et al. The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J Biol Chem 2003; 278 : 37175–82. [Google Scholar]
  24. Gahery-Segard H, Pialoux G, Charmeteau B, et al. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J Virol 2000; 74 : 1694–703. [Google Scholar]
  25. Gahery-Segard H, Pialoux G, Figueiredo S, et al. Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine : characterization of CD8+-T-cell epitopes recognized. J Virol 2003; 77 : 11220–31. [Google Scholar]
  26. Gahéry H, Choppin J, Bourgault I, et al. HIV preventive vaccine research at the ANRS : the lipopeptide vaccine approach. Thérapie 2005; 60 : 243–8. [Google Scholar]
  27. Launay O, Durier C, Desaint C, et al. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers : results of a phase 1 randomized trial. Plos One 2007; 2 : e725 . [Google Scholar]
  28. Gahéry H, Daniel N, Charmeteau B, et al. New CD4+ and CD8+ T-cell responses induced in chronically HIV-1 infected patients after immunizations with an HIV-1 lipopeptide vaccine. AIDS Res Hum Retr 2006; 22 : 684–94. [Google Scholar]
  29. Lévy Y, Durier C, Lascaux AS, et al. Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals. AIDS 2006; 20 : 405–13. [Google Scholar]
  30. Racape J, Connan F, Hoebeke J, et al. Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation. Proc Natl Acad Sci USA 2006; 103 : 18208–13. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.